CanSino Biologics Statistics
Total Valuation
CASBF has a market cap or net worth of 1.37 billion. The enterprise value is 1.21 billion.
| Market Cap | 1.37B |
| Enterprise Value | 1.21B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 165.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.81 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -23.25 |
| EV / Sales | 10.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.32% and return on invested capital (ROIC) is -3.10%.
| Return on Equity (ROE) | -7.32% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.10% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 77,611 |
| Profits Per Employee | -34,745 |
| Employee Count | 1,494 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.38% in the last 52 weeks. The beta is 1.35, so CASBF's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +52.38% |
| 50-Day Moving Average | 2.99 |
| 200-Day Moving Average | 6.55 |
| Relative Strength Index (RSI) | 46.11 |
| Average Volume (20 Days) | 4,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CASBF had revenue of 115.95 million and -51.91 million in losses. Loss per share was -0.21.
| Revenue | 115.95M |
| Gross Profit | 115.95M |
| Operating Income | -51.41M |
| Pretax Income | -52.23M |
| Net Income | -51.91M |
| EBITDA | -18.47M |
| EBIT | -51.41M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 449.80 million in cash and 288.02 million in debt, giving a net cash position of 161.78 million.
| Cash & Cash Equivalents | 449.80M |
| Total Debt | 288.02M |
| Net Cash | 161.78M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 693.70M |
| Book Value Per Share | 2.82 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -44.33% and -44.77%.
| Gross Margin | 100.00% |
| Operating Margin | -44.33% |
| Pretax Margin | -45.04% |
| Profit Margin | -44.77% |
| EBITDA Margin | -15.93% |
| EBIT Margin | -44.33% |
| FCF Margin | n/a |
Dividends & Yields
CASBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | -3.79% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |